A novel EMT-selective small molecule induces ER stress6cancercarcinomahumanFalseE-GEOD-556042073a-novel-emt-selective-small-molecule-induces-er-st2A novel five-gene signature predicts overall and recurrence-free survival in NSCLC8cancercellgenomelunglung cancernsclcstem cellhumanFalseE-GEOD-368214450a-novel-five-gene-signature-predicts-overall-and-r2Anticancer properties of distinct antimalaria drug classes91cancercellmalariahumanFalseE-GEOD-517392246anticancer-properties-of-distinct-antimalaria-drug5Antisense miRNA-221/222 (si221/222) and control inhibitor (GFP) treated fulvestrant-resistant breast cancer cells9breastbreast cancercancercelllinehumanFalseE-GEOD-197773544antisense-mirna-221222-si221222-and-control-inhibi1APC colon stage II90cancercoloncolon cancerhumanFalseE-GEOD-269063943apc-colon-stage-ii7A phase II study of adding the multikinase sorafenib to existing endocrine therapy in patients with metastatic ER-positive breast cancer.8breastbreast cancercancerdiseasehypokalemiahypophosphatemiamedianrashserumhumanFalseE-GEOD-408374576a-phase-ii-study-of-adding-the-multikinase-sorafen5A phenotype-based model for rational selection of novel targeted therapies in treating aggressive breast cancer14basalbreastcancercellhistonephosphatidylinositolprimary breast cancerhumanFalseE-GEOD-183313434a-phenotype-based-model-for-rational-selection-of1AR binding in prostate cancer cell lines VCaP and VCS24cancercellgenomeprostateprostate cancerhumanFalseE-GEOD-323564240ar-binding-in-prostate-cancer-cell-lines-vcap-and2Array-based gene expression in neuroblastic tumors3cancercellintermediatenervous systemneuroblastomahumanFalseE-GEOD-181393413array-based-gene-expression-in-neuroblastic-tumors2Artificially induced epithelial-mesenchymal transition in surgical subjects: its implications in clinical and basic cancer research40canceresophageal cancerhumanFalseE-GEOD-229543745artificially-induced-epithelial-mesenchymal-transi3